Occurrence of No-Harm Incidents and Adverse Events in Hospitalized Patients with Ischemic Stroke or TIA: A Cohort Study Using Trigger Tool Methodology.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
27 02 2022
Historique:
received: 10 01 2022
revised: 22 02 2022
accepted: 24 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 14 4 2022
Statut: epublish

Résumé

Adverse events (AEs)-healthcare caused events leading to patient harm or even death-are common in healthcare. Although it is a frequently investigated topic, systematic knowledge on this phenomenon in stroke patients is limited. To determine cumulative incidence of no-harm incidents and AEs, including their severity and preventability, a cohort study using trigger tool methodology for retrospective record review was designed. The study was carried out in a stroke center at a university hospital in the German speaking part of Switzerland. Electronic records from 150 randomly selected patient admissions for transient ischemic attack (TIA) or ischemic stroke, with or without acute recanalization therapy, were used. In total, 170 events (108 AEs and 62 no-harm incidents) were identified, affecting 83 patients (55.3%; 95% CI 47 to 63.4), corresponding to an event rate of 113 events/100 admissions or 142 events/1000 patient days. The three most frequent AEs were ischemic strokes (

Identifiants

pubmed: 35270487
pii: ijerph19052796
doi: 10.3390/ijerph19052796
pmc: PMC8910044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Stroke. 2007 Mar;38(3):1091-6
pubmed: 17272767
BMJ Qual Saf. 2018 Jul;27(7):502-511
pubmed: 28971884
BMC Health Serv Res. 2014 Dec 21;14:655
pubmed: 25527905
Scott Med J. 1957 May;2(5):200-15
pubmed: 13432835
J Eval Clin Pract. 2014 Feb;20(1):27-35
pubmed: 23890097
Int J Nurs Stud. 2020 Feb;102:103473
pubmed: 31810021
Neurology. 2007 Feb 20;68(8):550-5
pubmed: 17310024
Eur J Emerg Med. 2005 Apr;12(2):63-71
pubmed: 15756081
Swiss Med Wkly. 2019 Nov 10;149:w20149
pubmed: 31707720
J Gen Intern Med. 2003 Jan;18(1):61-7
pubmed: 12534766
BMC Health Serv Res. 2020 Apr 6;20(1):289
pubmed: 32252755
BMJ. 2019 Jul 17;366:l4185
pubmed: 31315828
BMJ Open. 2018 Jan 3;8(1):e019267
pubmed: 29301764
Neurology. 2017 Jul 18;89(3):284-290
pubmed: 28615436
Health Aff (Millwood). 2011 Apr;30(4):581-9
pubmed: 21471476
Stroke. 2001 Apr;32(4):891-7
pubmed: 11283388
Int J Qual Health Care. 2016 Dec 1;28(6):640-649
pubmed: 27664822
Qual Saf Health Care. 2008 Jun;17(3):216-23
pubmed: 18519629
Health Sci Rep. 2020 May 12;3(2):e160
pubmed: 32405540
Patient Saf Surg. 2013 Apr 15;7(1):10
pubmed: 23587448
Am J Hosp Pharm. 1991 Dec;48(12):2611-6
pubmed: 1814201
Int J Qual Health Care. 2014 Oct;26(5):553-60
pubmed: 25080549
BMJ. 2000 Mar 18;320(7237):768-70
pubmed: 10720363
Int J Qual Health Care. 2015 Oct;27(5):418-20
pubmed: 26294709
BMC Health Serv Res. 2018 Jul 4;18(1):521
pubmed: 29973258
BMC Health Serv Res. 2013 Jul 22;13:282
pubmed: 23876023
J Neurosci Nurs. 2017 Feb;49(1):31-36
pubmed: 28060219
Int J Risk Saf Med. 2015;27(1):11-21
pubmed: 25766063

Auteurs

Bartosch Nowak (B)

Department Head Organs, Spine- and Neuromedicine, University Hospital Basel, 4031 Basel, Switzerland.

René Schwendimann (R)

Patient Safety Office, University Hospital Basel, 4031 Basel, Switzerland.
Institute of Nursing Science, University of Basel, 4031 Basel, Switzerland.

Philippe Lyrer (P)

Department of Neurology and Stroke Center, University Hospital and University of Basel, 4031 Basel, Switzerland.

Leo H Bonati (LH)

Department of Neurology and Stroke Center, University Hospital and University of Basel, 4031 Basel, Switzerland.

Gian Marco De Marchis (GM)

Department of Neurology and Stroke Center, University Hospital and University of Basel, 4031 Basel, Switzerland.

Nils Peters (N)

Department of Neurology and Stroke Center, University Hospital and University of Basel, 4031 Basel, Switzerland.

Franziska Zúñiga (F)

Institute of Nursing Science, University of Basel, 4031 Basel, Switzerland.

Lili Saar (L)

Department of Neurology, Universitätsklinik Freiburg, 79106 Freiburg im Breisgau, Germany.

Maria Unbeck (M)

School of Health and Welfare, Dalarna University, 79131 Falun, Sweden.
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 17177 Stockholm, Sweden.

Michael Simon (M)

Institute of Nursing Science, University of Basel, 4031 Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH